Roth Capital Issues Negative Outlook for Celsius Earnings

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Equities researchers at Roth Capital reduced their Q3 2025 earnings per share (EPS) estimates for shares of Celsius in a note issued to investors on Thursday, May 29th. Roth Capital analyst S. Mcgowan now expects that the company will earn $0.13 per share for the quarter, down from their prior estimate of $0.22. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius' Q1 2026 earnings at $0.20 EPS, Q2 2026 earnings at $0.30 EPS, FY2026 earnings at $1.11 EPS and Q1 2027 earnings at $0.28 EPS.

A number of other equities analysts have also issued reports on CELH. Roth Mkm reaffirmed a "buy" rating and set a $38.00 price target on shares of Celsius in a research note on Friday, February 21st. LADENBURG THALM/SH SH decreased their price target on Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. Truist Financial raised Celsius from a "hold" rating to a "buy" rating and raised their price objective for the stock from $35.00 to $45.00 in a research note on Monday, March 31st. JPMorgan Chase & Co. raised their price objective on Celsius from $39.00 to $44.00 and gave the stock an "overweight" rating in a research note on Friday, May 2nd. Finally, B. Riley reissued a "buy" rating and set a $49.00 price objective (up from $44.00) on shares of Celsius in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $47.00.

Celsius Stock Up 3.6%

NASDAQ CELH traded up $1.30 on Friday, reaching $37.64. 9,776,913 shares of the stock traded hands, compared to its average volume of 8,035,393. The firm's fifty day simple moving average is $36.34 and its 200 day simple moving average is $30.39. The company has a market cap of $9.70 billion, a price-to-earnings ratio of 85.55, a P/E/G ratio of 2.90 and a beta of 1.65. Celsius has a 12 month low of $21.10 and a 12 month high of $79.52.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a net margin of 10.70% and a return on equity of 51.89%. The business had revenue of $329.28 million during the quarter, compared to analyst estimates of $349.09 million. During the same quarter in the prior year, the business earned $0.27 earnings per share. The firm's revenue was down 7.4% compared to the same quarter last year.

Insider Activity

In related news, insider Paul H. Storey sold 10,188 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the sale, the insider now directly owns 45,297 shares in the company, valued at approximately $1,167,303.69. This trade represents a 18.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joyce Russell sold 4,000 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $28.47, for a total value of $113,880.00. Following the sale, the director now owns 19,106 shares of the company's stock, valued at approximately $543,947.82. This represents a 17.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Institutional Trading of Celsius

Several hedge funds and other institutional investors have recently modified their holdings of the company. Geneos Wealth Management Inc. raised its holdings in shares of Celsius by 30.4% during the first quarter. Geneos Wealth Management Inc. now owns 26,804 shares of the company's stock worth $955,000 after acquiring an additional 6,250 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in shares of Celsius during the first quarter worth $647,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Celsius by 14.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 433,241 shares of the company's stock worth $15,432,000 after acquiring an additional 53,844 shares in the last quarter. United Services Automobile Association bought a new position in Celsius during the first quarter valued at about $334,000. Finally, Meiji Yasuda Asset Management Co Ltd. bought a new position in Celsius during the first quarter valued at about $254,000. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.